Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-10-239521
Filing Date
2010-10-28
Accepted
2010-10-28 14:25:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 1 dsc13da.htm SC 13D/A 14980
  Complete submission text file 0001193125-10-239521.txt   16935
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Subject) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45969 | Film No.: 101147534
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Filed by) CIK: 0001397144 (see all company filings)

EIN.: 980518585 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A